Research programme: small molecule therapeutics - Huadong Medicine/Insilico Medicine
Latest Information Update: 17 Sep 2021
At a glance
- Originator Huadong Medicine; InSilico Medicine
- Class Antineoplastics; Small molecules
- Mechanism of Action Protein-protein interaction inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer